{"id":54164,"name":"RECCE PHARMACEUTICALS","slug":"recce-pharmaceuticals","state":null,"country":"Australia","description":"Pharmaceutical company focusing on synthetic anti-infectives.","totalSpending":452000,"filings":15,"yearlySpending":[{"year":2023,"income":180000},{"year":2024,"income":180000},{"year":2025,"income":92000}],"issues":[{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"HCR","display":"Health Issues"}],"firms":["HORIZONS GLOBAL SOLUTIONS LLC"],"lobbyists":["JULIE LASSETER","STEPHEN BOYD","DAVID LASSETER"],"govEntities":["HOUSE OF REPRESENTATIVES"],"sampleDescriptions":["Supporting client with policy and advocacy related to synthetic anti-infectives used to address the urgent global health threat posed by superbugs and emerging viral pathogens.","Development of anti-infectives for use responding to military burns.","Development of anti-infectives for use responding to military burns.","Development of anti-infectives for use responding to military burns.","Development of anti-infectives for use responding to military burns."]}